While the oral option avoids needles, it may be harder to stick to because of its timing rules
This seems to be the business that fits into framework of growth and margins coming back of a good quality business which at the least should not be ignored The US business for Indian pharma companies in Q4 FY26 is defined by three interesting shifts: a) Complexity is the new competitive weapon b) Biosimilars are becoming real revenue contributors c) The semaglutide NDA/ANDA race Indian pharmas US business has permanently graduated from har-ghar generics yojana at declining prices to complex, differentiated products at stable-to-improving economics. Before we move on, If this deep dive is the kind of analysis that gets your investing brain firing, theres more where this came from
In clinical studies, patients using Semaglutide have seen an average weight loss of 15-18% of their body weight over the course of a year
Its suitable for mild to moderate pain, although patients should be cautioned against exceeding the recommended dosage to avoid liver damage
Being aware of the safety considerations can prevent you from any health risks
Start with a baseline assessment of diet, activity and health markers
